ARGX stock profile
Argen X SE Company Profile
Argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
Company information
- Company Name Argen X SE
- Industry Biological Product (except Diagnostic) Manufacturing
- CEO Tim Van Hauwermeiren
- Security Name Argen X SE - ADR
- Sector Manufacturing
- Employees 336
- Exchange NASDAQ
- Country Netherlands
- State Noord Brabant
- City Breda
- Address Willemstraat 5
- Phone 31763030488
- Website https://www.argenx.com/
- Zip 4811 AH
Peers
- OVAT-CA
- OVID
- OVIT
- OYST
Top Executives
- Entity Name
- Position
- Report Date
Related News
Datadog (NASDAQ: DDOG): AI Expansion Powers Revenue Growth, But Is the Stock Still a Buy?
TradingNEWS Archive
18.09.24
JPMorgan Chase (NYSE: JPM) Stock: A Smart Buy After Recent Pullback?
TradingNEWS Archive
17.09.24
IBM (NASDAQ: IBM) Takes Off as AI and Cloud Strategy Hit Full Speed
TradingNEWS Archive
16.09.24
Dell 70% Upside Potential (NASDAQ: DELL) Positioned for Explosive Growth Amid AI Surge and S&P 500 Inclusion
TradingNEWS Archive
13.09.24
Microsoft (NASDAQ: MSFT): Stock Price Soars Amid AI Expansion and Cloud Leadership
TradingNEWS Archive
12.09.24
Netflix Stock (NASDAQ: NFLX): Breaking Down Its Path to $700 and Beyond
TradingNEWS Archive
11.09.24